• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ SHIELDED IV CATHETER; INTERVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ SHIELDED IV CATHETER; INTERVASCULAR CATHETER Back to Search Results
Catalog Number 381467
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 08/24/2018
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event or Problem Description
It was reported before use a bd insyte¿ autoguard¿ shielded iv catheter had a sterile breach due to packaging that was slightly opened.There was no report of exposure, serious injury or medical intervention.
 
Additional Manufacturer Narrative
The product was manufactured on afa line 6 from (b)(6) 2016 thru (b)(6) 2016 and packaged on packaging line 11 from (b)(6) 2016 thru (b)(6) 2016.All required challenges samples and testing was performed per specification in accordance with the set-up and in process sampling plans.(b)(4) were issued for suspect wrinkled seal, but these are not related to this complaint.The defect of wrinkled seal occurs on the long side of the package and has not been linked to open seal complaints.Received 2 iag units from lot number 6308948.Unit packages of returned samples were open, but this is basis of the reported issue.Both of the units received were partially open at both sides.The product characteristics require a minimum of 1/8¿ seal width with adhesive transfer from the top web paper to the bottom web film.This characteristic was met.The key variables that affect the packaging seal are seal transfer/width and top web adhesive presence.Both of these variables were included in the investigation.Conclusion(s): supplier bd supplier oliver-tolas (ot) 29lp uses a standard reinforced paper that is common to many other suppliers, but the adhesive type and application is specific to oliver-tolas.There is sufficient evidence to demonstrate the ot material or adhesive application is the root cause.Due to continuous issues with ot, bd is moving to an alternate supplier for the top web material.(b)(4) was opened to investigate the package seal integrity complaints and implement corrective actions.
 
Event or Problem Description
It was reported before use a bd insyte autoguard shielded iv catheter had a sterile breach due to packaging that was slightly opened.There was no report of exposure, serious injury or medical intervention.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INSYTE¿ AUTOGUARD¿ SHIELDED IV CATHETER
Common Device Name
INTERVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
MDR Report Key7877545
Report Number1710034-2018-00634
Device Sequence Number19459839
Product Code FOZ
UDI-Device Identifier30382903814672
UDI-Public30382903814672
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
K952861
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,other,user facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 11/19/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date10/31/2019
Device Catalogue Number381467
Device Lot Number6308948
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/10/2018
Initial Date Received by Manufacturer 08/24/2018
Supplement Date Received by Manufacturer08/24/2018
Initial Report FDA Received Date09/14/2018
Supplement Report FDA Received Date11/20/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
-
-